1. Home
  2. FJET vs AMRN Comparison

FJET vs AMRN Comparison

Compare FJET & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FJET

Starfighters Space Inc. Common Stock

N/A

Current Price

$6.21

Market Cap

401.3M

ML Signal

N/A

Logo Amarin Corporation plc

AMRN

Amarin Corporation plc

HOLD

Current Price

$14.55

Market Cap

339.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FJET
AMRN
Founded
2022
1989
Country
United States
Ireland
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
401.3M
339.8M
IPO Year
N/A
1993

Fundamental Metrics

Financial Performance
Metric
FJET
AMRN
Price
$6.21
$14.55
Analyst Decision
Strong Sell
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
1.3M
93.4K
Earning Date
04-30-2026
03-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$226,733,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.59
$7.08
52 Week High
$31.50
$20.90

Technical Indicators

Market Signals
Indicator
FJET
AMRN
Relative Strength Index (RSI) 19.49 45.02
Support Level $6.60 $14.61
Resistance Level $11.78 $17.31
Average True Range (ATR) 1.08 0.84
MACD 0.13 -0.09
Stochastic Oscillator 5.94 7.77

Price Performance

Historical Comparison
FJET
AMRN

About FJET Starfighters Space Inc. Common Stock

Starfighters Space Inc is a commercial aerospace company based at NASA's Kennedy Space Center in Florida. The company operates supersonic aircraft capable of sustained Mach 2 flight and configured to carry payloads to high altitudes for air launch to space. Its activities include air launch operations, pilot and space flight training, support research, hypersonic testing, and other aerospace development programs. The company provides commercial space services and related aerospace capabilities.

About AMRN Amarin Corporation plc

Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.

Share on Social Networks: